EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumors
about
MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenograftsMolecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence ImagingA systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer.Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.BCRP expression in schwannoma, plexiform neurofibroma and MPNST.Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors.The Effects of Synthetically Modified Natural Compounds on ABC Transporters
P2860
Q35068041-92BB1D68-3A28-4BA4-892B-A3927359D5FBQ35902206-5E1E5E22-36F6-432D-AEBE-298FEB38810CQ36618871-C76B8990-838E-472C-8116-F65C1A0040A7Q37170669-FA720112-4E86-46D5-A780-3622F533EFC7Q38091335-55766C76-D4C3-435C-9FBE-7FDB7AAC87FAQ39084455-60483A8F-888E-4119-A509-0B62887CC5D4Q46067854-FDC1DD83-C67B-447D-A7F6-6B0F3B3C283BQ53082813-A12347B3-068B-4B12-9B7B-9D642ED0806CQ58791987-BC9B9A79-7F91-449F-9FE4-375DB9E94A7C
P2860
EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumors
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@ast
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@en
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@nl
type
label
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@ast
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@en
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@nl
prefLabel
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@ast
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@en
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@nl
P2093
P2860
P1433
P1476
EZN-2208 (PEG-SN38) overcomes ...... deficient mouse mammary tumors
@en
P2093
Jos Jonkers
Lee Greenberger
Olaf van Tellingen
Piet Borst
Serge A L Zander
Yixian Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0045248
P407
P577
2012-01-01T00:00:00Z